Company Overview and News


Add BXN
to your dashboard

Headline News

Bioxyne gets ready to raise

2017-04-13 proactiveinvestors.com.au
Bioxyne (ASX:BXN) has been granted a trading halt by the ASX, pending details of a capital raising.

Bioxyne gets ready to market its probiotics in China via JD.com

2017-02-21 proactiveinvestors.com.au
Bioxyne’s (ASX:BXN) shares were last trading 10.5% higher intra-day after signing an agreement to market its probiotic products in China using the e-commerce platform JD.com starting in Q2, 2017.

Bioxyne Ltd starts clinical trial for gut disease

2016-06-23 proactiveinvestors.com.au
Bioxyne Ltd (ASX:BXN) is the merged entity of Hunter Immunology and Probiomics. The company’s lead asset is a novel drug designed to treat chronic obstructive pulmonary disease.

Board Exercises Options

2016-05-05 asx.com.au

Appendix 4C - March quarterly

2016-04-26 asx.com.au

Bioxyne Announces 2016 Goals

2016-03-31 asx.com.au

Bioxyne Investor Presentation

2016-03-29 asx.com.au